Shareholders Will Probably Be Cautious Of Increasing INmune Bio, Inc.'s (NASDAQ:INMB) CEO Compensation At The Moment

Shareholders Will Probably Be Cautious Of Increasing INmune Bio, Inc.'s (NASDAQ:INMB) CEO Compensation At The Moment

INmune Bio's EPS declined by 4.8% over three years, resulting in a 59% loss for shareholders. Shareholders may express discontent at the AGM on July 19, especially regarding CEO compensation.

Read More

Did you find this insightful?